Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 499

1.

[Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].

Tian H, Song F, Zhang K, Liu Y.

Zhonghua Yi Xue Za Zhi. 2007 Dec 18;87(47):3349-52. Chinese.

PMID:
18478950
2.
3.
4.

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group..

Int Angiol. 2006 Dec;25(4):335-42.

PMID:
17164738
5.

The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.

Jameson SS, Baker PN, Charman SC, Deehan DJ, Reed MR, Gregg PJ, Van der Meulen JH.

J Bone Joint Surg Br. 2012 Jul;94(7):914-8. doi: 10.1302/0301-620X.94B7.29129.

PMID:
22733945
6.

The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.

Jameson SS, Charman SC, Gregg PJ, Reed MR, van der Meulen JH.

J Bone Joint Surg Br. 2011 Nov;93(11):1465-70. doi: 10.1302/0301-620X.93B11.27622.

PMID:
22058295
7.

A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.

Intermountain Joint Replacement Center Writing Committee..

J Arthroplasty. 2012 Jan;27(1):1-9.e2. doi: 10.1016/j.arth.2011.03.032. Epub 2011 May 31.

PMID:
21621959
8.
9.

DVT prophylaxis: better living through chemistry: affirms.

Pellegrini VD.

Orthopedics. 2010 Sep 7;33(9):642. doi: 10.3928/01477447-20100722-43.

PMID:
20839678
10.

AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study.

Lassen MR, Dahl OE, Mismetti P, Destrée D, Turpie AG.

J Thromb Haemost. 2009 Apr;7(4):566-72. doi: 10.1111/j.1538-7836.2009.03301.x. Epub 2009 Jan 24.

11.

Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.

Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL.

Anesthesiology. 2003 Sep;99(3):552-60; discussion 5A.

PMID:
12960538
12.

[Venous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational study].

Altintaş F, Gürbüz H, Erdemli B, Atilla B, Ustaoğlu RG, Oziç U, Savk O, Bayram H, Memik R, Akgün I, Göğüş A, Pestilci F, Konal A, Argün M, Oztürk I, Dabak N, Bilgen OF, Serin E, Onder C, Simşek A, Tözün R, Kinik H.

Acta Orthop Traumatol Turc. 2008 Nov-Dec;42(5):322-7. Turkish.

PMID:
19158452
13.

A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.

Abad JI, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin 6 Hours After Surgery Study Group..

Arch Orthop Trauma Surg. 2007 Oct;127(8):665-70. Epub 2006 Nov 7.

PMID:
17089172
14.

Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.

Whang PG, Lieberman JR.

Am J Orthop (Belle Mead NJ). 2002 Sep;31(9 Suppl):31-6. Review.

PMID:
12349893
15.

Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.

Asopa V, Cobain W, Martin D, Keene G, Bauze A.

ANZ J Surg. 2015 Sep;85(9):652-7. doi: 10.1111/ans.13174. Epub 2015 May 21.

PMID:
25997601
16.

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study.

Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Lassen MR, Mouret P, Rosencher N, Kälebo P, Panfilov S, Eskilson C, Andersson M, Freij A; EXPRESS Study Group..

J Thromb Haemost. 2003 Dec;1(12):2490-6.

17.

Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study.

Samama CM, Ravaud P, Parent F, Barré J, Mertl P, Mismetti P.

J Thromb Haemost. 2007 Dec;5(12):2360-7. Epub 2007 Oct 1.

18.

Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.

Samama CM, Vray M, Barré J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators..

Arch Intern Med. 2002 Oct 28;162(19):2191-6.

PMID:
12390061
19.

[Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].

Yang G, Lu H, Gao J, Kou B, Yuan Y, Xu B.

Zhonghua Wai Ke Za Zhi. 2000 Jan;38(1):25-7. Chinese.

PMID:
11831980
20.

Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.

Vekeman F, LaMori JC, Laliberté F, Nutescu E, Duh MS, Bookhart BK, Schein J, Dea K, Olson WH, Lefebvre P.

J Med Econ. 2011;14(3):324-34. doi: 10.3111/13696998.2011.578698. Epub 2011 Apr 20.

PMID:
21506632

Supplemental Content

Support Center